Viewing data from:

ENALAPRIL MALEATE

ANDA

ENALAPRIL MALEATE | A075483 | SENORES PHARMACEUTICALS INC

4 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: VASOTEC(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 11 NDCs

Highest NADAC/Unit

$0.0977

per ea

Lowest NADAC/Unit

$0.0647

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
69292054601ENALAPRIL MALEATE 20 MG TAB	$0.0977	EA	Generic	—	2026-06-17
69292054610ENALAPRIL MALEATE 20 MG TAB	$0.0977	EA	Generic	—	2026-06-17
68645045790ENALAPRIL MALEATE 20 MG TAB	$0.0977	EA	Generic	—	2026-06-17
69292054201ENALAPRIL MALEATE 5 MG TABLET	$0.0790	EA	Generic	—	2026-06-17
69292054210ENALAPRIL MALEATE 5 MG TABLET	$0.0790	EA	Generic	—	2026-06-17
68645045590ENALAPRIL MALEATE 5 MG TABLET	$0.0790	EA	Generic	—	2026-06-17

Showing 6 of 11 NDCs.

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain7 active DMFs13 inactive

5 active API suppliers hold Drug Master Files for this ingredient.

FARMHISPANIA SAENALAPRIL MALEATE

DMF 115251995

DR REDDYS LABORATORIES LTDENALAPRIL MALEATE, USP

DMF 138361998

ZHEJIANG HUAHAI PHARMACEUTICAL CO LTDENALAPRIL MALEATE USP

DMF 143551999

NEULAND LABORATORIES LTDENALAPRIL MALEATE

DMF 154342001

NEULAND LABORATORIES LTDENALAPRIL MALEATE USP

DMF 199842006

SRI KRISHNA PHARMACEUTICALS LTDENALAPRIL MALEATE USP PROCESS-II

DMF 402112024

NEULAND LABORATORIES LTDENALAPRIL MALEATE USP (PROCESS-II)

DMF 436182026

MERCK RESEARCH LABORATORIES DIV MERCK CO INCInactiveENALAPRIL MALEATE & DILTIAZEM ER TABLETS

DMF 111701994

MAPRIMED SAInactiveENALAPRIL MALEATE

DMF 116561995

ESTEVE QUIMICA SAInactiveENALAPRIL MALEATE

DMF 118661996

WOCKHARDT LTDInactiveENALAPRIL MALEATE

DMF 127801997

KRKA DD NOVO MESTOInactiveENALAPRIL MALEATE

DMF 128091997

GEDEON RICHTER LTDInactiveENALAPRIL MALEATE

DMF 129391998

MEDICHEM SAInactiveENALAPRIL MALEATE

DMF 130551998

LEK PHARMACEUTICALS DDInactiveENALAPRIL MALEATE, ACTIVE SUBSTANCE

DMF 131141998

SUN PHARMACEUTICAL INDUSTRIES LTDInactiveENALAPRIL MALEATE USP

DMF 138201998

CHEMSOURCE CORPInactiveENALAPRIL MALEATE DRUG SUBSTANCE

DMF 149382000

PHARMACEUTICAL WORKS POLPHARMA SAInactiveENALAPRIL MALEATE

DMF 189502005

APOTEX PHARMACHEM INDIA PVT LTDInactiveENALAPRIL MALEATE USP

DMF 190582005

MAPRIMED SAInactiveENALAPRIL MALEATE

DMF 203172007

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Aug 22, 2000	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (4)

Sort:

#001 — 2.5MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Aug 22, 2000

No patent or exclusivity listings for this strength.

#002 — 5MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Aug 22, 2000

#003 — 10MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Aug 22, 2000

#004 — 20MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Aug 22, 2000